Colgate-Palmolive Company's EPS Increases 2.2% in Q2 2025

Colgate-Palmolive Company reported its Q2 2025 financial results, with net sales reaching $5,110 million, a 1.0% increase compared to $5,058 million in Q2 2024. Net income attributable to Colgate-Palmolive Company rose by 1.6% to $743 million, up from $731 million in the prior-year quarter. The reported diluted earnings per share (EPS) stood at $0.91, marking a 2.2% increase from $0.89 in Q2 2024, surpassing the analyst EPS estimate of $0.89. However, revenue fell short of the analyst estimate of $5032.13 million.

Key Performance Drivers

The company achieved organic sales growth of 1.8% in Q2 2025, even with a negative impact from lower private label pet sales. Colgate-Palmolive Company maintained its leadership in the toothpaste market with a global share of 41.1% year-to-date and in manual toothbrushes with a global share of 32.4% year-to-date. The Hill's division recorded a 3.8% increase in net sales and a 2.0% organic sales growth, alongside a 13% rise in operating profit to $264 million.

Management Commentary and Strategic Outlook

Noel Wallace, Chairman, President and Chief Executive Officer, noted the company's continued growth in net sales, organic sales, and earnings per share despite challenging global market conditions. He emphasized the company's strong positioning to navigate market volatility, guided by its strategic framework focused on innovation and a robust global portfolio. Management reaffirmed its commitment to achieving its 2025 financial targets through diligent execution.

Colgate-Palmolive Company announced a new three-year productivity program designed to foster future growth and support its 2030 strategy. This program aims to optimize the company's organizational structure, enhance supply chain agility and efficiency, and streamline operations to reduce overhead costs. Cumulative pre-tax charges for this program are projected to range between $200 million and $300 million, with substantially all charges expected by December 31, 2028.

Updated Full-Year 2025 Guidance

For the full year 2025, Colgate-Palmolive Company continues to expect net sales to be up low single digits, now including a flat to low-single-digit negative impact from foreign exchange. Organic sales growth is anticipated to be at the low end of the 2% to 4% range, factoring in the planned exit from private label pet sales. Both GAAP gross profit margin and advertising investment are expected to remain roughly flat as a percentage of net sales, with GAAP earnings per share projected to be up low single digits.